Skip to main content
. 2019 May 5;2019:2460353. doi: 10.1155/2019/2460353

Figure 1.

Figure 1

TJ001 inhibits cell growth in prostate cancer cells. (a) The regulation of prostate cancer (p53 mutant DU145, p53 null PC3, and p53 wild-type LNCaP) cells proliferation by TJ001. Cell viability was measured by the MTT assay; optical density of MTT solution was measured at 590 nm. Data represent the average of three independent experiments [error bars are standard deviation (SD) (∗∗∗p < 0.001)]. (b) Cell viability after TJ001 treatment in normal cells. (c) Clonogenic ability of DU145, PC-3 and LNCaP cells after TJ001 treatment. Cells were treated with or without 200 μg/mL TJ001 for 7 days. The formed colonies were stained using 0.25% crystal violet. [Left panel; clonogenic plates with 0 μg/mL, right panel; clonogenic plates with 200 μg/mL TJ001.] (d) The graph showed the number of colonies in (c). Error bar represents SD (∗p < 0.05).